AMY BACKUS: Open Payments
NPI 1851737787 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,740 in 113 payments from 22 companies in 2025. Trend: 2023 $19 · 2024 $35 · 2025 $1,740
Food & beverage: $1,740
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $293 |
| ABBVIE INC. | 16 | $274 |
| PFIZER INC. | 18 | $234 |
| Lilly USA, LLC | 13 | $170 |
| Novo Nordisk Inc | 10 | $139 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $138 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $77 |
| Axsome Therapeutics, Inc. | 3 | $71 |
| SANOFI-AVENTIS U.S. LLC | 2 | $44 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
Products named: AIRSUPRA, NURTEC ODT, CAPLYTA, VRAYLAR, UBRELVY, MOUNJARO, FARXIGA, RELISTOR.
Industry payments across AR — which companies pay providers there.
